Which patients with cSCC could you omit adjuvant radiation following pathologic complete response following cemiplimab?
Answer from: Radiation Oncologist at Academic Institution
I think we need to distinguish between pCR as assessed by a random biopsy versus a complete resection of the involved primary site - the latter is rarely performed since the premise for giving cemiplimab in the first place would have been to avoid a morbid surgery. pCR is not always easy to assess f...